NanoVibronix, Inc. (NAOV)
USD 2.32
(-9.38%)
USD 2.32
(-9.38%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 4.97 Million USD | -3.98% |
| 2022 | 5.17 Million USD | -19.74% |
| 2021 | 6.45 Million USD | 30.81% |
| 2020 | 4.93 Million USD | -9.19% |
| 2019 | 5.43 Million USD | 21.71% |
| 2018 | 4.46 Million USD | 37.66% |
| 2017 | 3.24 Million USD | 31.95% |
| 2016 | 2.45 Million USD | 61.33% |
| 2015 | 1.52 Million USD | 15.29% |
| 2014 | 1.32 Million USD | 7.4% |
| 2013 | 1.23 Million USD | 38.2% |
| 2012 | 890 Thousand USD | 19.14% |
| 2011 | 747 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 1.1 Million USD | -10.55% |
| 2024 Q1 | 1.23 Million USD | -14.38% |
| 2023 Q2 | 1.22 Million USD | -5.04% |
| 2023 Q1 | 1.29 Million USD | -8.38% |
| 2023 Q3 | 1.01 Million USD | -16.82% |
| 2023 Q4 | 1.43 Million USD | 41.22% |
| 2023 FY | 4.97 Million USD | -3.98% |
| 2022 Q1 | 1.21 Million USD | -55.98% |
| 2022 Q2 | 1.54 Million USD | 27.18% |
| 2022 Q3 | 1 Million USD | -35.18% |
| 2022 Q4 | 1.4 Million USD | 40.24% |
| 2022 FY | 5.17 Million USD | -19.74% |
| 2021 Q1 | 1.39 Million USD | -11.17% |
| 2021 Q3 | 1.09 Million USD | -8.59% |
| 2021 Q4 | 2.76 Million USD | 152.46% |
| 2021 Q2 | 1.19 Million USD | -13.8% |
| 2021 FY | 6.45 Million USD | 30.81% |
| 2020 Q4 | 1.56 Million USD | 73.42% |
| 2020 Q2 | 1.5 Million USD | 57.2% |
| 2020 FY | 4.93 Million USD | -9.19% |
| 2020 Q1 | 958 Thousand USD | -21.02% |
| 2020 Q3 | 903 Thousand USD | -40.04% |
| 2019 Q1 | 2.27 Million USD | 64.69% |
| 2019 FY | 5.43 Million USD | 21.71% |
| 2019 Q4 | 1.21 Million USD | 44.4% |
| 2019 Q3 | 840 Thousand USD | -23.84% |
| 2019 Q2 | 1.1 Million USD | -51.54% |
| 2018 Q3 | 1.33 Million USD | 47.89% |
| 2018 FY | 4.46 Million USD | 37.66% |
| 2018 Q1 | 845 Thousand USD | -19.91% |
| 2018 Q2 | 902 Thousand USD | 6.75% |
| 2018 Q4 | 1.38 Million USD | 3.6% |
| 2017 FY | 3.24 Million USD | 31.95% |
| 2017 Q1 | 837 Thousand USD | -4.78% |
| 2017 Q2 | 694 Thousand USD | -17.08% |
| 2017 Q3 | 656 Thousand USD | -5.48% |
| 2017 Q4 | 1.05 Million USD | 60.82% |
| 2016 Q1 | 504 Thousand USD | 3.7% |
| 2016 FY | 2.45 Million USD | 61.33% |
| 2016 Q4 | 879 Thousand USD | 51.81% |
| 2016 Q3 | 579 Thousand USD | 16.73% |
| 2016 Q2 | 496 Thousand USD | -1.59% |
| 2015 FY | 1.52 Million USD | 15.29% |
| 2015 Q1 | 330 Thousand USD | 2.48% |
| 2015 Q2 | 339 Thousand USD | 2.73% |
| 2015 Q3 | 368 Thousand USD | 8.55% |
| 2015 Q4 | 486 Thousand USD | 32.07% |
| 2014 Q4 | 322 Thousand USD | -36.61% |
| 2014 FY | 1.32 Million USD | 7.4% |
| 2014 Q1 | 184 Thousand USD | -1.6% |
| 2014 Q2 | 307 Thousand USD | 66.85% |
| 2014 Q3 | 508 Thousand USD | 65.47% |
| 2013 Q4 | 187 Thousand USD | 33.57% |
| 2013 Q3 | 140 Thousand USD | 0.0% |
| 2013 FY | 1.23 Million USD | 38.2% |
| 2013 Q1 | 683 Thousand USD | 384.4% |
| 2012 FY | 890 Thousand USD | 19.14% |
| 2012 Q4 | 141 Thousand USD | -50.35% |
| 2012 Q3 | 284 Thousand USD | 0.0% |
| 2011 FY | 747 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | 55.693% |
| Cerus Corporation | 143.15 Million USD | 96.526% |
| OrthoPediatrics Corp. | 137.01 Million USD | 96.371% |
| PetVivo Holdings, Inc. | 11.36 Million USD | 56.227% |
| Talis Biomedical Corporation | 67.18 Million USD | 92.598% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 80.065% |
| Inogen, Inc. | 236.08 Million USD | 97.894% |
| Spectral AI, Inc. | 20.86 Million USD | 76.165% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 91.119% |
| CVRx, Inc. | 76.14 Million USD | 93.469% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -40.958% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | 60.181% |
| Orthofix Medical Inc. | 667.42 Million USD | 99.255% |
| Venus Concept Inc. | 80.47 Million USD | 93.821% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 91.21% |
| Bioventus Inc. | 409.91 Million USD | 98.787% |
| BrainsWay Ltd. | 28.01 Million USD | 82.251% |
| Envoy Medical, Inc. | 17.89 Million USD | 72.215% |
| electroCore, Inc. | 32.03 Million USD | 84.474% |
| IceCure Medical Ltd | 16.87 Million USD | 70.532% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 88.28% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | 71.797% |
| MaxCyte, Inc. | 84.84 Million USD | 94.139% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | 59.933% |
| Nexalin Technology, Inc. | 5.78 Million USD | 13.982% |
| PAVmed Inc | 64.82 Million USD | 92.329% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 90.264% |
| RxSight, Inc. | 103.85 Million USD | 95.211% |
| Sight Sciences, Inc. | 126.44 Million USD | 96.067% |
| SI-BONE, Inc. | 156.35 Million USD | 96.819% |
| TELA Bio, Inc. | 84.18 Million USD | 94.093% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 92.901% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 97.555% |
| LivaNova PLC | 843.54 Million USD | 99.41% |
| 908 Devices Inc. | 68.08 Million USD | 92.695% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 98.972% |
| Nemaura Medical Inc. | 7.13 Million USD | 30.338% |
| NeuroPace, Inc. | 75.29 Million USD | 93.395% |
| LENSAR, Inc. | 33.33 Million USD | 85.082% |
| Apyx Medical Corporation | 51.01 Million USD | 90.252% |
| Cutera, Inc. | 197.72 Million USD | 97.485% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | 79.932% |
| BioSig Technologies, Inc. | 28.53 Million USD | 82.569% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 97.403% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 86.209% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 99.405% |
| Axonics, Inc. | 270.2 Million USD | 98.16% |
| Outset Medical, Inc. | 198.77 Million USD | 97.498% |
| IRIDEX Corporation | 31.81 Million USD | 84.369% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 97.241% |
| IRadimed Corporation | 30.12 Million USD | 83.491% |
| Tivic Health Systems, Inc. | 8.53 Million USD | 41.714% |
| INVO Bioscience, Inc. | 7.85 Million USD | 36.676% |
| Telesis Bio, Inc. | 63.48 Million USD | 92.167% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 94.949% |
| Varex Imaging Corporation | 224.8 Million USD | 97.788% |
| Quipt Home Medical Corp. | 148.66 Million USD | 96.655% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | 57.579% |
| Pulmonx Corporation | 112.68 Million USD | 95.587% |
| Dynatronics Corporation | 9.9 Million USD | 49.808% |
| Modular Medical, Inc. | 17.52 Million USD | 71.63% |
| ReShape Lifesciences Inc. | 20.18 Million USD | 75.365% |
| Semler Scientific, Inc. | 38.94 Million USD | 87.23% |
| InMode Ltd. | 215.68 Million USD | 97.694% |
| Bruker Corporation | 1.07 Billion USD | 99.538% |
| Cytosorbents Corporation | 48.33 Million USD | 89.712% |
| DexCom, Inc. | 1.69 Billion USD | 99.706% |
| Align Technology, Inc. | 2.07 Billion USD | 99.761% |
| Viveve Medical, Inc. | 22.17 Million USD | 77.572% |
| ZimVie Inc. | 275.12 Million USD | 98.192% |
| Movano Inc. | 29.69 Million USD | 83.25% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 96.377% |
| Nexalin Technology, Inc. | 5.78 Million USD | 13.982% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -40.958% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 99.172% |
| Profound Medical Corp. | 33.6 Million USD | 85.201% |
| Insulet Corporation | 939.9 Million USD | 99.471% |
| enVVeno Medical Corporation | 25.23 Million USD | 80.296% |
| Surmodics, Inc. | 98.69 Million USD | 94.961% |
| iCAD, Inc. | 22.22 Million USD | 77.624% |
| Nuwellis, Inc. | 22.61 Million USD | 78.008% |
| Biotricity, Inc. | 17.18 Million USD | 71.061% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 98.885% |
| Aethlon Medical, Inc. | 12.27 Million USD | 59.495% |
| InspireMD, Inc. | 22.95 Million USD | 78.331% |
| PAVmed Inc. | 64.82 Million USD | 92.329% |
| BIOLASE, Inc. | 34.66 Million USD | 85.652% |
| Beyond Air, Inc. | 61.7 Million USD | 91.94% |
| FONAR Corporation | 28.6 Million USD | 82.615% |
| AxoGen, Inc. | 149.33 Million USD | 96.67% |
| Vivani Medical, Inc. | 26.96 Million USD | 81.558% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 97.192% |
| Inari Medical, Inc. | 448.59 Million USD | 98.891% |
| UFP Technologies, Inc. | 58.08 Million USD | 91.439% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -0.921% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | 21.292% |
| Tenon Medical, Inc. | 16.96 Million USD | 70.692% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | 32.734% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 88.724% |
| AdaptHealth Corp. | 1.07 Billion USD | 99.539% |
| Sintx Technologies, Inc. | 15.2 Million USD | 67.285% |
| Quanterix Corporation | 118.1 Million USD | 95.789% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | 57.579% |
| Sensus Healthcare, Inc. | 14.44 Million USD | 65.566% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 98.734% |
| TransMedics Group, Inc. | 182.82 Million USD | 97.28% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 82.28% |
| NeuroMetrix, Inc. | 11.09 Million USD | 55.194% |
| Hyperfine, Inc. | 52.87 Million USD | 90.594% |
| Establishment Labs Holdings Inc. | 172 Million USD | 97.109% |
| Biomerica, Inc. | 6.97 Million USD | 28.733% |
| Bone Biologics Corporation | 9.42 Million USD | 47.255% |
| AVITA Medical, Inc. | 80.77 Million USD | 93.844% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | 51.771% |
| Silk Road Medical, Inc | 186.35 Million USD | 97.331% |